Brown Trout Management »

Catalyst Pharmaceutical Partners shares owned by Brown Trout Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Brown Trout Management from 13F filings

Historical chart of Brown Trout Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Brown Trout Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Brown Trout Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.9M 123k 23.91

More positions owned by Brown Trout Management

Nuvalent Inc-a (NUVL)
Apogee Therapeutics (APGE)
Chart Industries (GTLS)
Bandwidth Note 0.500% 4/0 (Principal)
Taylor Morrison Hom (TMHC)
Sabre Glbl Note 7.320% 8/0 (Principal)
Rapid7 Note 0.250% 3/1 (Principal)
Mgp Ingredients Note 1.875%11/1 (Principal)
Veritone Note 1.750%11/1 (Principal)
Amphastar Pharmaceuticals In Note 2.000% 3/1 (Principal)
The Realreal Note 1.000% 3/0 (Principal)
Five9 Note 1.000% 3/1 (Principal)
Shake Shack Note 3/0 (Principal)
Etsy Note 0.250% 6/1 (Principal)
Hewlett Packard Enterprise C 7.625 Mand Conv (HPE.PC)

View all positions for Brown Trout Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
State Street Corporation
American Century Companies
Vanguard Capital Management
Dimensional Fund Advisors
Glazer Capital
Jpmorgan Chase & Co
Geode Capital Management
HBK Investments
Morgan Stanley
Vanguard Portfolio Management
Jupiter Topco
Qube Research & Technologies
Renaissance Technologies
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners